Martin Broadstock

889 total citations
16 papers, 362 citations indexed

About

Martin Broadstock is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Martin Broadstock has authored 16 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Martin Broadstock's work include Alzheimer's disease research and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neurological disorders and treatments (4 papers). Martin Broadstock is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neurological disorders and treatments (4 papers). Martin Broadstock collaborates with scholars based in United Kingdom, United States and Sweden. Martin Broadstock's co-authors include Clive Ballard, Anne Corbett, Matthew J. Betts, Paul J. Austin, Susan Duty, Dag Aarsland, Elena M. Ribé, Christina Elliott, S.N. Mitchell and Richard Killick and has published in prestigious journals such as Clinical Infectious Diseases, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Martin Broadstock

16 papers receiving 353 citations

Peers

Countries citing papers authored by Martin Broadstock

Since Specialization

Citations

This map shows the geographic impact of Martin Broadstock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Broadstock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Broadstock more than expected).

Fields of papers citing papers by Martin Broadstock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Broadstock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Broadstock. The network helps show where Martin Broadstock may publish in the future.

Co-authorship network of co-authors of Martin Broadstock

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Broadstock. A scholar is included among the top collaborators of Martin Broadstock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Broadstock. Martin Broadstock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil 2023 ·International Journal of Molecular Sciences ·Richard Killick, Christina Elliott, Elena M. Ribé, Martin Broadstock, Clive Ballard, Dag Aarsland, Gareth Williams	9
2	Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia 2019 ·Neurochemistry International ·(unknown), (unknown), (unknown), Martin Broadstock, Lan Yu, David Howlett, Dag Aarsland, Clive Ballard, Paul T. Francis	8
3	Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease 2019 ·Fluids and Barriers of the CNS ·(unknown), (unknown), (unknown), (unknown), (unknown), Hao Wang, (unknown), Khondaker Miraz Rahman, Martin Broadstock, Suzanne Reeves, Sarah Thomas	45
4	Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction 2019 ·Clinical Infectious Diseases ·Megan E. Carey, (unknown), Martin Broadstock, Roderick Bailey, Adwoa Bentsi-Enchill, Heidi J. Larson	2
5	A role for APP in Wnt signalling links synapse loss with β-amyloid production 2018 ·Translational Psychiatry ·Christina Elliott, Ana I. Rojo, Elena M. Ribé, Martin Broadstock, Weiming Xia, Peter J. Morin, Mikhail A. Semenov, George S. Baillie, Antonio Cuadrado, Raya Al‐Shawi, Clive Ballard, J. Paul Simons, Richard Killick	80
6	Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia 2017 ·Journal of Alzheimer s Disease ·Amani Alghamdi, Julie Vallortigara, David Howlett, Martin Broadstock, Tibor Hortobágyi, Clive Ballard, Alan Thomas, John T. O’Brien, Dag Aarsland, Johannes Attems, Paul T. Francis, David Whitfield	14
7	Intrastriatal Delivery of Integration-Deficient Lentiviral Vectors in a Rat Model of Parkinson’s Disease 2016 ·Methods in molecular biology ·Ngoc Lu‐Nguyen, Martin Broadstock, Rafael J. Yáñez‐Muñoz	1
8	Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats 2015 ·Human Gene Therapy ·Ngoc Lu‐Nguyen, Martin Broadstock, Rafael J. Yáñez‐Muñoz	5
9	A genetically immortalized human stem cell line: a promising new tool for Alzheimer’s disease therapy 2015 ·PubMed ·Nicha Puangmalai, Alyma Somani, Wipawan Thangnipon, Clive Ballard, Martin Broadstock	4
10	Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies 2014 ·Expert Opinion on Pharmacotherapy ·Martin Broadstock, Clive Ballard, Anne Corbett	52
11	Transgenic Expression of Human Glial Cell Line-Derived Neurotrophic Factor from Integration-Deficient Lentiviral Vectors is Neuroprotective in a Rodent Model of Parkinson's Disease 2014 ·Human Gene Therapy ·Ngoc Lu‐Nguyen, Martin Broadstock, Maximilian G. Schliesser, Cynthia C. Bartholomae, Christof von Kalle, Manfred Schmidt, Rafael J. Yáñez‐Muñoz	19
12	Novel pharmaceuticals in the treatment of psychosis in Parkinson’s disease 2014 ·Expert Review of Clinical Pharmacology ·Martin Broadstock, Clive Ballard, Anne Corbett	8
13	Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia 2012 ·Current Neurology and Neuroscience Reports ·Dag Aarsland, Clive Ballard, Arvid Rongve, Martin Broadstock, Per Svenningsson	28
14	Antiparkinsonian potential of targeting group III metabotropic glutamate receptor subtypes in the rodent substantia nigra pars reticulata 2011 ·British Journal of Pharmacology ·Martin Broadstock, Paul J. Austin, Matthew J. Betts, Susan Duty	41
15	Neurochemical changes in a double transgenic mouse model of Alzheimer's disease fed a pro-oxidant diet 2010 ·Neurochemistry International ·(unknown), Mohammad S. Alavijeh, Alan M. Palmer, Cathy Mitchelmore, David Howlett, Paul T. Francis, Martin Broadstock, Jill Richardson	7
16	Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease 2010 ·British Journal of Pharmacology ·Paul J. Austin, Matthew J. Betts, Martin Broadstock, (unknown), S.N. Mitchell, Susan Duty	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact